Cargando…
Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents f...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928857/ https://www.ncbi.nlm.nih.gov/pubmed/34919494 http://dx.doi.org/10.1080/21645515.2021.2007708 |
_version_ | 1784670729043705856 |
---|---|
author | Kotta, Ibolya Kalcza-Janosi, Kinga Szabo, Kinga Marschalko, Eszter Eniko |
author_facet | Kotta, Ibolya Kalcza-Janosi, Kinga Szabo, Kinga Marschalko, Eszter Eniko |
author_sort | Kotta, Ibolya |
collection | PubMed |
description | The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents filled out the scale. Exploratory and confirmatory factor analysis was conducted to identify latent constructs underlying participants′ responses. Findings show a robust three-factor solution for the 15-item CoVaH with high factor loadings on each factor: skepticism, risk perception and fear of Covid-19 vaccine. The CoVaH displayed very good fit indices (KMO = .94, RMSEA = 0.049, CFI = .983) and internal consistencies (α values > .89) and was found to have proper convergent, concurrent and discriminant validity in identifying Covid-19 vaccine hesitancy in the general population. The new scale adds to the literature through the identification of the fear of COVID-19 vaccines, as a newly highlighted explanatory variable of COVID-19 vaccine hesitancy, besides the other formerly identified components. The scale, available in English and Hungarian, allows the assessment of vaccine uptake hesitancy and has the potential to help targeted interventions, considering individual factors that interfere with vaccination acceptance. |
format | Online Article Text |
id | pubmed-8928857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-89288572022-03-18 Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale Kotta, Ibolya Kalcza-Janosi, Kinga Szabo, Kinga Marschalko, Eszter Eniko Hum Vaccin Immunother Coronavirus – Research Paper The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents filled out the scale. Exploratory and confirmatory factor analysis was conducted to identify latent constructs underlying participants′ responses. Findings show a robust three-factor solution for the 15-item CoVaH with high factor loadings on each factor: skepticism, risk perception and fear of Covid-19 vaccine. The CoVaH displayed very good fit indices (KMO = .94, RMSEA = 0.049, CFI = .983) and internal consistencies (α values > .89) and was found to have proper convergent, concurrent and discriminant validity in identifying Covid-19 vaccine hesitancy in the general population. The new scale adds to the literature through the identification of the fear of COVID-19 vaccines, as a newly highlighted explanatory variable of COVID-19 vaccine hesitancy, besides the other formerly identified components. The scale, available in English and Hungarian, allows the assessment of vaccine uptake hesitancy and has the potential to help targeted interventions, considering individual factors that interfere with vaccination acceptance. Taylor & Francis 2021-12-17 /pmc/articles/PMC8928857/ /pubmed/34919494 http://dx.doi.org/10.1080/21645515.2021.2007708 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Coronavirus – Research Paper Kotta, Ibolya Kalcza-Janosi, Kinga Szabo, Kinga Marschalko, Eszter Eniko Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
title | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
title_full | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
title_fullStr | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
title_full_unstemmed | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
title_short | Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale |
title_sort | development and validation of the multidimensional covid-19 vaccine hesitancy scale |
topic | Coronavirus – Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928857/ https://www.ncbi.nlm.nih.gov/pubmed/34919494 http://dx.doi.org/10.1080/21645515.2021.2007708 |
work_keys_str_mv | AT kottaibolya developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale AT kalczajanosikinga developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale AT szabokinga developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale AT marschalkoesztereniko developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale |